These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 990034

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects on rat urinary kallikrein excretion of bumetanide, bendroflumethiazide and hydralazine.
    Nielsen K, Arrigoni-Martelli E.
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):267-72. PubMed ID: 576555
    [Abstract] [Full Text] [Related]

  • 3. Studies on interaction of timolol, hydrochlorothiazide and amiloride in the rat.
    Scriabine A, Watson LS, Ludden CT, Russo HF, Bohidar NR.
    Clin Exp Pharmacol Physiol; 1980 Feb; 7(2):209-13. PubMed ID: 7379349
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of the antihypertensive effect of hydrochlorothiazide in dogs after suppression of renin release by beta-adrenergic blockade.
    Sweet CS, Mandradjieff M.
    Clin Sci Mol Med; 1975 Feb; 48(2):147-51. PubMed ID: 234821
    [Abstract] [Full Text] [Related]

  • 5. Effect of timolol on hydralazine-induced increase in plasma renin activity in spontaneously hypertensive and normotensive rats.
    Riley RL, Scriabine A, Watson LS.
    Proc Soc Exp Biol Med; 1976 Dec; 153(3):454-8. PubMed ID: 1013157
    [No Abstract] [Full Text] [Related]

  • 6. Amelioration of bendrofluazide-induced hypokalemia by timolol.
    Hettiarachchi J, Ramsay LE, Davies DL, Fraser R, Watson WS.
    Clin Pharmacol Ther; 1977 Jul; 22(1):58-62. PubMed ID: 326460
    [Abstract] [Full Text] [Related]

  • 7. Preclinical safety evaluation of the nadolol/bendroflumethiazide combination in mice, rats, and dogs.
    Stevens AC, Keysser CH, Kulesza JS, Miller MM, Myhre JL, Sibley PL, Yoon YH, Keim GR.
    Fundam Appl Toxicol; 1984 Jun; 4(3 Pt 1):360-9. PubMed ID: 6745529
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive and renal effects of captopril in spontaneously hypertensive rats: evidence against a role of the kallikrein-kinin system.
    Filep J, Rigter B, Földes-Filep E.
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):222-7. PubMed ID: 2441174
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of alacepril on renin-angiotensin-aldosterone system and kallikrein-kinin-prostaglandin system in experimental animals.
    Hosoki K, Takeyama K, Minato H, Fukuya F, Kawahara S, Kadokawa T.
    Arzneimittelforschung; 1986 Aug; 36(1):77-83. PubMed ID: 3006712
    [Abstract] [Full Text] [Related]

  • 11. Renin-angiotensin and kallikrein-kinin systems in sodium homeostasis and hypertension in rats.
    Johnston CI, Matthews PG, Dax E.
    Clin Sci Mol Med Suppl; 1976 Dec; 3():283s-286s. PubMed ID: 1071628
    [Abstract] [Full Text] [Related]

  • 12. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J.
    Ann Acad Med Stetin; 1996 Dec; 42():123-38. PubMed ID: 9199117
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Modulation of urinary kallikrein and plasma renin activities does not affect established hypertension in the fawn-hooded rat.
    Gilboa N, Rudofsky UH, Phillips MI, Magro AM.
    Nephron; 1989 Dec; 51(1):61-6. PubMed ID: 2644567
    [Abstract] [Full Text] [Related]

  • 15. Effect of ACTH administration on urinary kallikrein excretion in man.
    Whitworth JA, van Leeuwen BH, Hannah MC, Scoggins BA, Thatcher R.
    Clin Exp Pharmacol Physiol; 1984 Dec; 11(1):87-90. PubMed ID: 6325055
    [Abstract] [Full Text] [Related]

  • 16. Urinary kallikrein in hypertensive animal models.
    Keiser HR, Geller RG, Margolius HS, Pisano JJ.
    Fed Proc; 1976 Feb; 35(2):199-202. PubMed ID: 1248654
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protective effect of cicletanine on hypertension-induced decreases in the renal kallikrein-kinin and prostaglandin systems in stroke-prone spontaneously hypertensive rats.
    Emond C, Bompart G, Rakotoarivony J, Bascands JL, Pecher C, Adam A, Tarrade T, Berthet P, Girolami JP.
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):601-8. PubMed ID: 1280717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.